NVAX Jan 2025 25.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.3800

-0.2400

(-14.81%)

As of 02:02PM EDT. Market open.

Loading interactive chart…

Zacks
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers are included in this Analyst Blog.
Zacks
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
Novavax, Inc (NVAX) and Fulcrum Therapeutics, Inc (FULC) are in the spotlight following license agreements with pharma giant Sanofi.
FX Empire
Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
The past five days have been a rollercoaster for Novavax investors, as the share price of the company skyrocketed by over 200% following the announcement of a major deal with French pharmaceutical giant Sanofi.